Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 35 studies | 33% ± 14% | |
B cell | 32 studies | 25% ± 6% | |
endothelial cell | 25 studies | 27% ± 10% | |
classical monocyte | 22 studies | 33% ± 10% | |
non-classical monocyte | 20 studies | 33% ± 11% | |
monocyte | 19 studies | 33% ± 9% | |
conventional dendritic cell | 19 studies | 27% ± 11% | |
memory B cell | 17 studies | 23% ± 6% | |
endothelial cell of lymphatic vessel | 16 studies | 28% ± 8% | |
naive B cell | 16 studies | 21% ± 5% | |
microglial cell | 15 studies | 48% ± 19% | |
plasmacytoid dendritic cell | 15 studies | 37% ± 13% | |
myeloid cell | 15 studies | 33% ± 14% | |
dendritic cell | 14 studies | 28% ± 14% | |
natural killer cell | 14 studies | 19% ± 4% | |
pericyte | 14 studies | 24% ± 6% | |
capillary endothelial cell | 12 studies | 22% ± 5% | |
fibroblast | 11 studies | 26% ± 8% | |
smooth muscle cell | 11 studies | 26% ± 6% | |
neutrophil | 9 studies | 25% ± 8% | |
CD16-negative, CD56-bright natural killer cell, human | 9 studies | 21% ± 3% | |
alveolar macrophage | 8 studies | 33% ± 13% | |
endothelial cell of artery | 8 studies | 23% ± 6% | |
mast cell | 8 studies | 19% ± 3% | |
glutamatergic neuron | 7 studies | 41% ± 24% | |
mononuclear phagocyte | 6 studies | 35% ± 9% | |
platelet | 6 studies | 23% ± 8% | |
epithelial cell | 6 studies | 26% ± 8% | |
vein endothelial cell | 6 studies | 28% ± 10% | |
endothelial cell of vascular tree | 6 studies | 20% ± 4% | |
hematopoietic precursor cell | 5 studies | 30% ± 6% | |
leukocyte | 5 studies | 28% ± 12% | |
basal cell | 5 studies | 23% ± 9% | |
brush cell | 5 studies | 54% ± 18% | |
ciliated cell | 5 studies | 21% ± 3% | |
innate lymphoid cell | 5 studies | 23% ± 5% | |
GABAergic neuron | 4 studies | 41% ± 15% | |
megakaryocyte | 4 studies | 27% ± 8% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 19% ± 4% | |
immature B cell | 4 studies | 24% ± 4% | |
adipocyte | 4 studies | 28% ± 10% | |
abnormal cell | 4 studies | 25% ± 3% | |
goblet cell | 4 studies | 22% ± 5% | |
mature NK T cell | 3 studies | 18% ± 2% | |
glomerular endothelial cell | 3 studies | 23% ± 2% | |
neuron | 3 studies | 34% ± 11% | |
tissue-resident macrophage | 3 studies | 32% ± 10% | |
lymphocyte | 3 studies | 25% ± 4% | |
germinal center B cell | 3 studies | 26% ± 5% | |
intermediate monocyte | 3 studies | 39% ± 20% | |
myofibroblast cell | 3 studies | 18% ± 2% | |
enteroendocrine cell | 3 studies | 23% ± 2% | |
adventitial cell | 3 studies | 24% ± 4% | |
gamma-delta T cell | 3 studies | 21% ± 2% | |
group 3 innate lymphoid cell | 3 studies | 24% ± 3% | |
mesothelial cell | 3 studies | 33% ± 10% | |
hematopoietic stem cell | 3 studies | 19% ± 3% | |
astrocyte | 3 studies | 34% ± 22% | |
interneuron | 3 studies | 42% ± 19% | |
kidney loop of Henle epithelial cell | 3 studies | 18% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 11 studies | 23% ± 5% | |
brain | 9 studies | 30% ± 17% | |
peripheral blood | 8 studies | 24% ± 8% | |
liver | 4 studies | 25% ± 8% | |
bone marrow | 3 studies | 18% ± 3% | |
intestine | 3 studies | 20% ± 6% | |
adipose | 3 studies | 28% ± 7% | |
kidney | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2996.77 | 1445 / 1445 | 100% | 30.98 | 183 / 183 |
lung | 100% | 3600.40 | 578 / 578 | 99% | 36.53 | 1149 / 1155 |
kidney | 100% | 2373.96 | 89 / 89 | 99% | 61.29 | 896 / 901 |
bladder | 100% | 2807.76 | 21 / 21 | 98% | 30.13 | 494 / 504 |
prostate | 99% | 1150.65 | 242 / 245 | 98% | 22.80 | 493 / 502 |
intestine | 100% | 2372.55 | 966 / 966 | 95% | 30.21 | 503 / 527 |
breast | 100% | 2923.68 | 459 / 459 | 91% | 20.91 | 1020 / 1118 |
adrenal gland | 100% | 3400.07 | 258 / 258 | 90% | 25.27 | 206 / 230 |
skin | 99% | 1625.91 | 1783 / 1809 | 91% | 33.69 | 429 / 472 |
thymus | 97% | 931.40 | 633 / 653 | 88% | 13.03 | 535 / 605 |
stomach | 82% | 1423.38 | 294 / 359 | 98% | 30.16 | 281 / 286 |
uterus | 86% | 813.24 | 147 / 170 | 90% | 21.45 | 413 / 459 |
ovary | 99% | 1742.38 | 179 / 180 | 73% | 11.70 | 316 / 430 |
brain | 83% | 1189.03 | 2202 / 2642 | 84% | 22.02 | 591 / 705 |
pancreas | 60% | 383.88 | 196 / 328 | 98% | 41.93 | 175 / 178 |
liver | 46% | 300.41 | 103 / 226 | 70% | 11.14 | 283 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 56.22 | 29 / 29 |
spleen | 100% | 3358.97 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.31 | 1 / 1 |
adipose | 100% | 2973.26 | 1201 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 6274.66 | 926 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 21.66 | 43 / 45 |
blood vessel | 92% | 1659.76 | 1226 / 1335 | 0% | 0 | 0 / 0 |
muscle | 82% | 685.54 | 657 / 803 | 0% | 0 | 0 / 0 |
heart | 47% | 347.51 | 405 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.39 | 4 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0042113 | Biological process | B cell activation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | SKAP2 |
Protein name | Src kinase associated phosphoprotein 2 Src kinase-associated phosphoprotein 2 (Pyk2/RAFTK-associated protein) (Retinoic acid-induced protein 70) (SKAP55 homolog) (SKAP-55HOM) (SKAP-HOM) (Src family-associated phosphoprotein 2) (Src kinase-associated phosphoprotein 55-related protein) (Src-associated adapter protein with PH and SH3 domains) |
Synonyms | PRAP RA70 SCAP2 SKAP55R SAPS |
Description | FUNCTION: May be involved in B-cell and macrophage adhesion processes. In B-cells, may act by coupling the B-cell receptor (BCR) to integrin activation. May play a role in src signaling pathway. . |
Accessions | C9JQ17 ENST00000345317.7 O75563 ENST00000432747.1 |